Anne Plum

Title: The Innovations of Anne Plum

Introduction

Anne Plum is a notable inventor based in Birkeroed, Denmark. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of insulin compositions. With a total of 2 patents to her name, her work has the potential to impact diabetes treatment significantly.

Latest Patents

Among her latest patents is an invention related to insulin compositions with a high content of zinc atoms per six molecules of acylated insulin. This innovative approach allows for the mixing of acylated insulin with rapid-acting insulin analogues, such as Asp B28 human insulin. Another significant patent involves pharmaceutical compositions comprising GLP-1 peptides or extendin-4 combined with a basal insulin peptide. This composition is designed for parenteral administration and includes at least six zinc atoms per six insulin molecules, enhancing its effectiveness.

Career Highlights

Anne Plum is currently associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. Her work at Novo Nordisk has positioned her as a key player in the advancement of insulin therapies.

Collaborations

Throughout her career, Anne has collaborated with esteemed colleagues such as Svend Havelund and Frantisek Hubalek. These partnerships have fostered innovation and contributed to the success of her research endeavors.

Conclusion

Anne Plum's contributions to insulin composition and pharmaceutical formulations highlight her role as a pioneering inventor in the field. Her work continues to influence diabetes treatment and showcases the importance of innovation in healthcare.